Personalized Digital Remote Monitoring for Elderly Patients
NCT ID: NCT06845917
Last Updated: 2025-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
700 participants
INTERVENTIONAL
2025-06-15
2027-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Key Research Questions
This study will assess:
* Unplanned Hospitalizations: Does EPOCA RMS reduce the total number of unplanned hospital days over 12 months?
* Quality of Life \& Costs: What is the impact of EPOCA RMS on patients' quality of life and overall healthcare costs?
* Survival Rates: Does EPOCA RMS improve survival rates compared to standard care?
Participant Criteria
Participants must:
* Be 75 years or older with at least three chronic conditions.
* Have experienced a hospitalization or fall in the past year.
* Be randomly assigned to either the EPOCA RMS group or a control group receiving standard care.
* Be monitored for 12 months, with data collected at multiple time points.
Study Design
* Type: Multicenter, randomized controlled trial (RCT).
* Sites: Conducted across 8 hospitals in France.
* Duration: 12-month follow-up.
* Sample Size: 700 participants (350 per group).
* Intervention Group: Remote monitoring through the EPOCA RMS, integrating connected devices and medical coordination.
* Control Group: Standard care follow-up.
Expected Outcomes
* Reduced unplanned hospital stays and emergency visits.
* Improved quality of life and patient satisfaction.
* Comprehensive cost-effectiveness analysis and economic impact assessment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home Electronic Monitoring of Chronic Heart Failure
NCT02486887
Patient Perspective on Remote Monitoring of Cardiovascular Implantable Electronic Devices
NCT01691586
Benfit of Remote Monitoring in Pacemaker
NCT06043570
Telemedicine - Evaluation of the Impact of a Telemedicine Device (DTM) on the Prevention of Emergency Department Visits and Hospitalizations of Nursing Home Residents Aged Polypathological
NCT04008472
Effects of Remote Patient Monitoring on Chronic Disease Management
NCT03127852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control arm: standard follow-up
Patients in the control group will receive standard medical care from their general practitioner or their geriatrician. In addition to the standard follow-up, they will be contacted for data collection purposes.
No interventions assigned to this group
Intervention arm: Patients followed by a Remote Monitoring System
Remote Patient Monitoring system
RMS consists of an initial assessment visit and system installation: A nurse trained by the EPOCA team will conduct a comprehensive assessment of the patient's needs during a home visit within 48 hours of enrollment. This includes collecting biometric measurements, socio-economic profile, and completing a questionnaire with the patient. The initial visit also includes a consultation with a physician. All the information is transmitted to a digital platform accordingly a personalized care plan (PCP) will be defined. The nurse installs a telemonitoring kit for the patient and gives them instructions on how to use it.
The PCP manager will be responsible for implementing and overseeing the patient care plan, including informing the relevant stakeholders. Patients will be monitored via regular data feedback from the connected devices, the physician and the PCP manager. The PCP manager will treat any identified anomalies or abnormalities and implement the necessary changes on the PCP.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remote Patient Monitoring system
RMS consists of an initial assessment visit and system installation: A nurse trained by the EPOCA team will conduct a comprehensive assessment of the patient's needs during a home visit within 48 hours of enrollment. This includes collecting biometric measurements, socio-economic profile, and completing a questionnaire with the patient. The initial visit also includes a consultation with a physician. All the information is transmitted to a digital platform accordingly a personalized care plan (PCP) will be defined. The nurse installs a telemonitoring kit for the patient and gives them instructions on how to use it.
The PCP manager will be responsible for implementing and overseeing the patient care plan, including informing the relevant stakeholders. Patients will be monitored via regular data feedback from the connected devices, the physician and the PCP manager. The PCP manager will treat any identified anomalies or abnormalities and implement the necessary changes on the PCP.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Three or more chronic pathologies (e.g., diabetes, heart disease, depression, cancer, respiratory failure, renal failure, dementia),
* Hospitalization or fall at least once in the previous year (Y-1),
* Recently discharged from the emergency department (within 24 hours),
* Patients, with or without caregivers, who accepted to participate and provided informed consent.
Exclusion Criteria
* Patients enrolled in another clinical trial
* Suicidal or hetero-aggressive risk in a patient alone at home,
* Homeless patients,
* Patients protected by the following French legal measure: "sauvegarde de justice"
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
EPOCA U&I
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EPOCA-CT-2024-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.